TXNIP and triple-A syndrome: VSMC-specific TXNIP deletion (<i>ApoE</i> <sup>-/-</sup> <i>TXNIP</i> <sup><i>SM-/-</i></sup> ) significantly reduced AAA incidence, aortic remodeling, and elastic fiber degradation, establishing its essential role in disease progression.